[1]
H. Abdel-Razeq and R. Mansour, “Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants”, World J Oncol, vol. 17, no. 1, pp. 14–24, Jan. 2026, doi: 10.14740/wjon2692.